LVW Advisors »

Nektar Therapeutics shares owned by LVW Advisors

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by LVW Advisors from 13F filings

Historical chart of LVW Advisors investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by LVW Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by LVW Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $217k 3.0k 71.95

More positions owned by LVW Advisors

Spdr Series Trust State Street Spd (SPYM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Bd Index Fds Intermed Term (BIV)
Apple (AAPL)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Capital Group Gbl Growth Eqt Shs Creation Uni (CGGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ab Active Etfs Tax Aware Interm (TAFM)
Capital Group International SHS (CGIE)
Ishares Tr Shrt Nat Mun Etf (SUB)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Growth Etf (VUG)

View all positions for LVW Advisors

Top funds holding Nektar Therapeutics

BVF
Two Seas Capital
Vanguard Capital Management
Susquehanna International
Vanguard Group
Two Sigma Investments
BlackRock
Citadel Advisors
Morgan Stanley
Armistice Capital
Invesco
Prosight Management
Sofinnova Ventures
Woodline Partners
Lord, Abbett & Co

View all funds holding Nektar Therapeutics